A Phase I––II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

Author: Lassen Ulrik   Jensen Lars Henrik   Sorensen Morten   Rohrberg Kristoffer S.   Ujmajuridze Zaza   Jakobsen Anders  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.50, Iss.3, 2011-04, pp. : 448-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content